GlassScriptPhysician profile
Lawrence G Davis
NPI 1104905835
$4,076.62
in general payments reported to CMS, 2019-2025
9 companies · $744 in 2025
The $744 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $367 · 2021: $339 · 2022: $649 · 2023: $147 · 2024: $1,830 · 2025: $744.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,917 · Travel and Lodging: $804.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,916.84 |
| Travel and Lodging | $804.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,053.20 | 2021-2024 | Spyglass Discover, Embold Fibered, Therasphere Y90 Glass Microspheres 10 Gbq |
| Ethicon US, LLC | $554.99 | 2019-2024 | Neuwave |
| Sirtex Medical INC | $359.12 | 2024-2025 | Sir-Spheres Microspheres |
| Inari Medical, INC. | $289.56 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Stryker Corporation | $288.36 | 2025 | Flowtriever, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Penumbra, INC. | $160.00 | 2025 | Indigo System |
| Histosonics, INC. | $159.98 | 2025 | |
| Biocompatibles, INC. | $113.66 | 2019 | |
| Terumo Medical Corporation | $97.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.